Abstract
OBJECTIVE: Many patients with pelvic inflammatory disease (PID) present to their general practitioners. Chlamydia trachomatis is the organism most commonly implicated in this condition. This study aims to examine how well PID is managed in the primary care setting and highlight areas for improvement. METHODS: The study was performed by sending postal questionnaires to 180 randomly selected general practitioners in Birmingham. Given the example of a woman presenting clinically with PID, the doctors were asked questions on diagnosis and treatment. To assess factors that may influence the answers, they were also asked about their sex, year of qualification, and postgraduate training. RESULTS: 139 questionnaires (77%) were returned. 91.4% of the respondents feel confident in managing patients with PID, and only 9.3% would usually refer these patients on. However, 54.7% do not perform an endocervical swab for C trachomatis, 37.4% do not include anti-chlamydial antibiotics in their treatment regimen, and 24.5% do not advise sexual partners to be screened. Female doctors, those with higher degrees, or obstetrics and gynaecology experience were more likely to give anti-chlamydial therapy, but no factors of the respondents significantly influenced contact tracing behaviour. CONCLUSIONS: The management of a patient presenting with PID should include investigation for C trachomatis and treatment with an appropriate antibiotic. As PID is often a sexually transmitted disease, contact tracing of sexual partners should be undertaken. The study suggests that a significant proportion of general practitioners would not have offered optimal management to patients with PID.
Full Text
The Full Text of this article is available as a PDF (89.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bevan C. D., Johal B. J., Mumtaz G., Ridgway G. L., Siddle N. C. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol. 1995 May;102(5):407–414. doi: 10.1111/j.1471-0528.1995.tb11294.x. [DOI] [PubMed] [Google Scholar]
- Corcoran G. D., Ridgway G. L. Antibiotic chemotherapy of bacterial sexually transmitted diseases in adults: a review. Int J STD AIDS. 1994 May-Jun;5(3):165–171. doi: 10.1177/095646249400500302. [DOI] [PubMed] [Google Scholar]
- Eynon-Lewis A. Audit of the management of pelvic inflammatory disease in general practice. J R Coll Gen Pract. 1988 Nov;38(316):492–493. [PMC free article] [PubMed] [Google Scholar]
- Kamwendo F., Johansson E., Moi H., Forslin L., Danielsson D. Gonorrhea, genital chlamydial infection, and nonspecific urethritis in male partners of women hospitalized and treated for acute pelvic inflammatory disease. Sex Transm Dis. 1993 May-Jun;20(3):143–146. doi: 10.1097/00007435-199305000-00005. [DOI] [PubMed] [Google Scholar]
- Martin D. H., Mroczkowski T. F., Dalu Z. A., McCarty J., Jones R. B., Hopkins S. J., Johnson R. B. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24;327(13):921–925. doi: 10.1056/NEJM199209243271304. [DOI] [PubMed] [Google Scholar]
- Pearce J. M. Pelvic inflammatory disease. BMJ. 1990 Apr 28;300(6732):1090–1091. doi: 10.1136/bmj.300.6732.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ridgway G. L. Advances in the antimicrobial therapy of chlamydial genital infections. J Infect. 1992 Jul;25 (Suppl 1):51–59. doi: 10.1016/0163-4453(92)92037-j. [DOI] [PubMed] [Google Scholar]
- Robinson A. J., Greenhouse P. Prevention of recurrent pelvic infection by contact tracing: a commonsense approach. Br J Obstet Gynaecol. 1996 Sep;103(9):859–861. doi: 10.1111/j.1471-0528.1996.tb09901.x. [DOI] [PubMed] [Google Scholar]
- Weström L., Wölner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med. 1993 Feb;69(1):9–17. doi: 10.1136/sti.69.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]